Shalby Limited has rescheduled its earnings conference call to discuss the financial results for the first quarter of fiscal year 2027 (Q1FY27). The company announced on July 29, 2026, that the call, initially scheduled for Friday, August 7, 2026, at 4:00 PM IST, will now be held on Thursday, August 13, 2026, at 10:30 AM IST. This procedural update ensures stakeholders have adequate notice to participate in the discussion regarding the latest quarterly performance.

The announcement was made via a letter to the Listing Department of the National Stock Exchange of India Ltd and the Corporate Service Department of BSE Limited. The communication references an earlier intimation dated July 16, 2026, which had confirmed the original date. Tushar Shah, Vice President and Company Secretary, signed the disclosure, requesting that the revised schedule be taken on record. The company emphasized that all other details regarding the conference call remain unchanged.

Elara Securities (India) Private Limited is hosting the conference call. The session will feature key executives from Shalby Limited providing insights into the quarter’s operational and financial highlights. The management team participating in the call includes Dr. Vikram Shah, Chairman and Managing Director; Mr. Shanay Shah, President; and Mr. Amit Kumar, Chief Financial Officer. Their presence indicates a comprehensive review of the company’s strategic direction and financial health for the period.

Other senior leaders joining the discussion include Dr. Nishita Shukla, Chief Operating Officer of Shalby Hospitals; Mr. Deepak Anand, Chief Executive Officer of Shalby MedTech; Mr. Babu Thomas, Chief Human Resources Officer; and Mr. Jigar Todi from Investor Relations. This broad representation suggests that the call will cover both hospital operations and the medical technology segment, reflecting the diversified nature of Shalby’s business model.

Investors and analysts can access the call through multiple channels. Participants may register via Diamond Pass or dial in using universal numbers such as +91 22 6280 1146. Toll-free options are available for international attendees, including the US (1 866 746 2133), UK (0 808 101 1573), Singapore (800 101 2045), Hong Kong (800 964 448), and Australia (0080014243444). The timing also accommodates global markets, starting at 06:00 AM UK time and 01:30 AM East Coast US time.

Key Details of the Earnings Call

The rescheduling does not alter the agenda, which remains focused on reviewing Q1FY27 earnings. Investors are advised to update their calendars accordingly to ensure participation in this critical update on Shalby’s financial trajectory.

Shalby Limited has rescheduled its upcoming Board of Directors meeting from August 5, 2026, to Wednesday, August 12, 2026. The healthcare services provider cited unavoidable exigencies as the reason for the change in date. This procedural update affects the timeline for potential announcements regarding financial results or strategic decisions that were originally slated for the earlier date.

The company notified the National Stock Exchange of India Ltd and BSE Limited on July 27, 2026, regarding the rescheduling. The intimation references a previous communication dated July 15, 2026, which had initially scheduled the meeting for August 5. The Board meeting is now set to take place on August 12, 2026, with no further changes indicated at this stage.

Trading Window Status

In accordance with Shalby Limited's Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the company's securities remains closed. The window originally closed on July 1, 2026, prior to the initial scheduled meeting date. The company confirmed that this closure will continue until 48 hours after the conclusion of the rescheduled Board meeting on August 12, 2026. Investors are advised to refrain from trading during this restricted period to comply with insider trading regulations.

Regulatory Compliance

The disclosure was made in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Tushar Shah, Vice President & Company Secretary of Shalby Limited, signed the intimation letter. The company's registered office is located in Ahmedabad, Gujarat.

What This Means for Investors

The rescheduling of the board meeting delays any potential corporate actions or financial disclosures that were expected on August 5. While the specific agenda items for the August 12 meeting have not been detailed in this intimation, such meetings typically involve the approval of quarterly financial results, dividend declarations, or other material contracts. The extended closure of the trading window ensures a level playing field for all investors by preventing those with access to unpublished price sensitive information from trading ahead of public disclosures. Investors should monitor subsequent filings for the outcome of the August 12 meeting.